EMA-CO protocol

chemotherapy protocol containing etoposide, methotrexate & dactinomycin (EMA) , vincristine & cyclophosphamide (CO); EMA & CO are given on alternate weeks; for therapy of gestational trophoblastic tumors

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Therapy Context: Research Results

Experts

1.	Lurain, John R: 1 article (10/2006)
2.	Schink, Julian C: 1 article (10/2006)
3.	Singh, Diljeet K: 1 article (10/2006)

Related Diseases

1.	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 10/01/2006 - "Over 93% of 30 patients with metastatic high-risk gestational trophoblastic neoplasia treated initially with the EMA-CO protocol, often in conjunction with brain irradiation, surgical resection of sites of persistent tumor and salvage platinum-based chemotherapy, were cured."
2.	Neoplasms (Cancer) 10/01/2006 - "Over 93% of 30 patients with metastatic high-risk gestational trophoblastic neoplasia treated initially with the EMA-CO protocol, often in conjunction with brain irradiation, surgical resection of sites of persistent tumor and salvage platinum-based chemotherapy, were cured."
3.	Choriocarcinoma 04/01/1992 - "[Treatment of primary therapy refractory choriocarcinoma using the EMA-CO protocol]."

Related Drugs and Biologics

1.	Platinum

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Therapeutics